Pediatrix Medical Group (NYSE:MD) Trading Down 10.7%

Pediatrix Medical Group, Inc. (NYSE:MDGet Rating)’s stock price was down 10.7% during mid-day trading on Thursday . The company traded as low as $20.00 and last traded at $20.00. Approximately 5,759 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 596,670 shares. The stock had previously closed at $22.39.

Analyst Ratings Changes

A number of analysts recently issued reports on MD shares. Mizuho lowered their target price on Pediatrix Medical Group from $28.00 to $23.00 in a research report on Monday, May 2nd. TheStreet downgraded Pediatrix Medical Group from a “b-” rating to a “c+” rating in a research report on Wednesday, April 13th. Deutsche Bank Aktiengesellschaft lowered their target price on Pediatrix Medical Group from $24.00 to $16.00 in a research report on Tuesday, May 10th. Finally, StockNews.com downgraded Pediatrix Medical Group from a “buy” rating to a “hold” rating in a research report on Monday, May 2nd. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $26.50.

Pediatrix Medical Group Trading Up 1.7 %

The business has a 50-day simple moving average of $21.27 and a two-hundred day simple moving average of $22.13. The stock has a market cap of $1.72 billion, a price-to-earnings ratio of 20.08, a P/E/G ratio of 1.20 and a beta of 1.84. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.60 and a quick ratio of 1.63.

Pediatrix Medical Group (NYSE:MDGet Rating) last posted its earnings results on Thursday, August 4th. The company reported $0.47 EPS for the quarter, beating the consensus estimate of $0.43 by $0.04. Pediatrix Medical Group had a return on equity of 16.15% and a net margin of 4.30%. The company had revenue of $486.00 million for the quarter, compared to the consensus estimate of $491.54 million. During the same quarter in the prior year, the business earned $0.36 earnings per share. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. Equities analysts forecast that Pediatrix Medical Group, Inc. will post 1.73 EPS for the current fiscal year.

Hedge Funds Weigh In On Pediatrix Medical Group

Several institutional investors and hedge funds have recently made changes to their positions in MD. Vanguard Group Inc. boosted its stake in shares of Pediatrix Medical Group by 2.3% in the first quarter. Vanguard Group Inc. now owns 9,541,964 shares of the company’s stock valued at $224,045,000 after buying an additional 212,150 shares during the period. Alliancebernstein L.P. boosted its stake in shares of Pediatrix Medical Group by 11.9% in the fourth quarter. Alliancebernstein L.P. now owns 7,359,083 shares of the company’s stock valued at $200,241,000 after buying an additional 781,646 shares during the period. Lazard Asset Management LLC boosted its stake in shares of Pediatrix Medical Group by 24.3% in the first quarter. Lazard Asset Management LLC now owns 3,263,699 shares of the company’s stock valued at $76,631,000 after buying an additional 637,798 shares during the period. State Street Corp boosted its stake in shares of Pediatrix Medical Group by 1.8% in the fourth quarter. State Street Corp now owns 3,211,149 shares of the company’s stock valued at $87,375,000 after buying an additional 57,309 shares during the period. Finally, River Road Asset Management LLC boosted its stake in shares of Pediatrix Medical Group by 98.3% in the first quarter. River Road Asset Management LLC now owns 2,607,218 shares of the company’s stock valued at $61,217,000 after buying an additional 1,292,605 shares during the period. Institutional investors and hedge funds own 95.68% of the company’s stock.

Pediatrix Medical Group Company Profile

(Get Rating)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Featured Stories

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.